ArticleCardiovascular drugs and therapy2025

US Population Eligibility and Estimated Impact of Tirzepatide Treatment on Obesity Prevalence and Cardiovascular Disease Events.

Nathan D Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.